These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 20001909)

  • 1. N-heterocyclic dipeptide aldehyde calpain inhibitors.
    Jones SA; Jones MA; McNabb SB; Aitken SG; Coxon JM; Abell AD
    Protein Pept Lett; 2009; 16(12):1466-72. PubMed ID: 20001909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, biological evaluation and molecular modelling of N-heterocyclic dipeptide aldehydes as selective calpain inhibitors.
    Jones MA; Morton JD; Coxon JM; McNabb SB; Lee HY; Aitken SG; Mehrtens JM; Robertson LJ; Neffe AT; Miyamoto S; Bickerstaffe R; Gately K; Wood JM; Abell AD
    Bioorg Med Chem; 2008 Jul; 16(14):6911-23. PubMed ID: 18571418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational Design of Calpain Inhibitors Based on Calpastatin Peptidomimetics.
    Low KE; Ler S; Chen KJ; Campbell RL; Hickey JL; Tan J; Scully CC; Davies PL; Yudin AK; Zaretsky S
    J Med Chem; 2016 Jun; 59(11):5403-15. PubMed ID: 27148623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation into the P3 binding domain of m-calpain using photoswitchable diazo- and triazene-dipeptide aldehydes: new anticataract agents.
    Abell AD; Jones MA; Neffe AT; Aitken SG; Cain TP; Payne RJ; McNabb SB; Coxon JM; Stuart BG; Pearson D; Lee HY; Morton JD
    J Med Chem; 2007 Jun; 50(12):2916-20. PubMed ID: 17497840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of N-terminal heterocycles in hydrogen bonding to α-chymotrypsin.
    Schumann NC; Bruning J; Marshall AC; Abell AD
    Bioorg Med Chem Lett; 2019 Feb; 29(3):396-399. PubMed ID: 30579793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of eight-membered cyclic pseudo-dipeptides.
    Abell AD; Brown KM; Coxon JM; Jones MA; Miyamoto S; Neffe AT; Nikkel JM; Stuart BG
    Peptides; 2005 Feb; 26(2):251-8. PubMed ID: 15629536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of action of thalassospiramides, a new class of calpain inhibitors.
    Lu L; Meehan MJ; Gu S; Chen Z; Zhang W; Zhang G; Liu L; Huang X; Dorrestein PC; Xu Y; Moore BS; Qian PY
    Sci Rep; 2015 Mar; 5():8783. PubMed ID: 25740631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular modeling: a search for a calpain inhibitor as a new treatment for cataractogenesis.
    Stuart BG; Coxon JM; Morton JD; Abell AD; McDonald DQ; Aitken SG; Jones MA; Bickerstaffe R
    J Med Chem; 2011 Nov; 54(21):7503-22. PubMed ID: 21955158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1,2-Benzothiazine 1,1-dioxide P(2)-P(3) peptide mimetic aldehyde calpain I inhibitors.
    Wells GJ; Tao M; Josef KA; Bihovsky R
    J Med Chem; 2001 Oct; 44(21):3488-503. PubMed ID: 11585453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cocrystal structures of primed side-extending alpha-ketoamide inhibitors reveal novel calpain-inhibitor aromatic interactions.
    Qian J; Cuerrier D; Davies PL; Li Z; Powers JC; Campbell RL
    J Med Chem; 2008 Sep; 51(17):5264-70. PubMed ID: 18702462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent peptide alpha-ketohydroxamate inhibitors of recombinant human calpain I.
    Josef KA; Kauer FW; Bihovsky R
    Bioorg Med Chem Lett; 2001 Oct; 11(19):2615-7. PubMed ID: 11551762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The synthesis of ketomethylene pseudopeptide analogues of dipeptide aldehyde inhibitors of calpain.
    Angelastro MR; Marquart AL; Mehdi S; Koehl JR; Vaz RJ; Bey P; Peet NP
    Bioorg Med Chem Lett; 1999 Jan; 9(2):139-40. PubMed ID: 10021915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New tripeptide-based macrocyclic calpain inhibitors formed by N-alkylation of histidine.
    Chen H; Jiao W; Jones MA; Coxon JM; Morton JD; Bickerstaffe R; Pehere AD; Zvarec O; Abell AD
    Chem Biodivers; 2012 Nov; 9(11):2473-84. PubMed ID: 23161629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-chlamydial activities of cell-permeable hydrophobic dipeptide-containing derivatives.
    Itoh R; Soejima T; Hiromatsu K
    J Infect Chemother; 2019 Dec; 25(12):987-994. PubMed ID: 31230920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclic dipeptides exhibit potency for scavenging radicals.
    Furukawa T; Akutagawa T; Funatani H; Uchida T; Hotta Y; Niwa M; Takaya Y
    Bioorg Med Chem; 2012 Mar; 20(6):2002-9. PubMed ID: 22356736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental Manipulation of Calpain Activity In Vitro.
    Kitagawa S
    Methods Mol Biol; 2019; 1915():209-218. PubMed ID: 30617806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploration of the importance of the P2-P3-NHCO-moiety in a potent di- or tripeptide inhibitor of calpain I: insights into the development of nonpeptidic inhibitors of calpain I.
    Chatterjee S; Iqbal M; Mallya S; Senadhi SE; O'Kane TM; McKenna BA; Bozyczko-Coyne D; Kauer JC; Siman R; Mallamo JP
    Bioorg Med Chem; 1998 May; 6(5):509-22. PubMed ID: 9629465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calpains: attractive targets for the development of synthetic inhibitors.
    Pietsch M; Chua KC; Abell AD
    Curr Top Med Chem; 2010; 10(3):270-93. PubMed ID: 20166953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new cell-permeable calpain inhibitor.
    Fiorino F; Gil-Parrado S; Assfalg-Machleidt I; Machleidt W; Moroder L
    J Pept Sci; 2007 Jan; 13(1):70-3. PubMed ID: 17019744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biosynthetic multitasking facilitates thalassospiramide structural diversity in marine bacteria.
    Ross AC; Xu Y; Lu L; Kersten RD; Shao Z; Al-Suwailem AM; Dorrestein PC; Qian PY; Moore BS
    J Am Chem Soc; 2013 Jan; 135(3):1155-62. PubMed ID: 23270364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.